FDA Inspection 1091323 — Colgate-Palmolive Company
The FDA completed an inspection of Colgate-Palmolive Company on May 30, 2019 in Piscataway, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 30, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Piscataway, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)
Citations
| ID | CFR | Description |
|---|---|---|
| 8936 | FDCA 760(b)(1) | No label copy submitted with AE report (non-Rx drug) |